
Ocean Biomedical
(OTC) OCEA
Ocean Biomedical Financials at a Glance
Market Cap
$46.50K
Revenue (TTM)
$0.00
Net Income (TTM)
-$30.72M
EPS (TTM)
-$0.91
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.00
Volume
44,424
Open
$0.00
Price
$0.00
Volume
44,424
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.02
Estimated Earnings Date
Jun 3, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.00
Volume
44,424
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.02
Estimated Earnings Date
Jun 3, 2026
OCEA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ocean Biomedical
Industry
Biotechnology
Sector
Health CareEmployees
7
CEO
M. Michelle Berrey, MD
Website
www.oceanbiomedical.comHeadquarters
Providence, RI 02903, US
OCEA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-4%
Return on Assets
-5%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$46.50K
Shares Outstanding
232.37M
Volume
44.42K
Avg. Volume
52.03K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$0.00
EBITDA
$0.00
Operating Cash Flow
-$4.18M
Capital Expenditure
$0.00
Free Cash Flow
-$4.18M
Cash & ST Invst.
$0.00
Total Debt
$16.30M
Ocean Biomedical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$46.50K
N/A
Market Cap/Employee
$6.64K
N/A
Employees
7
N/A
Net Income
-$8.24M
-163.4%
EBITDA
-$7.90M
-157.9%
Quarterly Fundamentals
Net Cash
-$9.35M
+5.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$9.35M
-5.1%
Return on Assets
-5.03%
N/A
Return on Invested Capital
-4.35%
N/A
Free Cash Flow
-$356.00K
+26.6%
Operating Cash Flow
-$356.00K
+26.6%
